Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Y Chung

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Immunological consequences of macrophage-mediated clearance of apoptotic cellsSunjung Kim, Elaine Y Chung, Xiaojing Ma
Cell Research|February 14, 2006
Regulation of cytokine production during phagocytosis of apoptotic cellsElaine Y Chung, Sun Jung Kim, Xiao Jing Ma
Cancer Biology & Therapy|June 15, 2007
Aiding and ABT'ing Treatment for GlioblastomaElaine Y Chung, Michael Dews, Amit Maity, et al.
The Journal of Clinical Investigation|May 2, 2012
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesisElaine Y Chung, James N Psathas, Duonan Yu, et al.
Current Immunology Reviews|November 2, 2010
Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionJianguo Liu, Shanjin Cao, Sunjung Kim, et al.
Molecular and Cellular Biology|December 2, 2004
PRAM-1 is required for optimal integrin-dependent neutrophil functionRegina A Clemens, Sally A Newbrough, Elaine Y Chung, et al.
British Journal of Haematology|April 4, 2018
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphomaFilippo Spriano, Elaine Y Chung, Nicolo' Panini, et al.
Immunity|December 21, 2007
Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1Elaine Y Chung, Jianguo Liu, Yoichiro Homma, et al.
Cancer Biology & Therapy|August 19, 2008
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA clusterElaine Y Chung, Michael Dews, Diana Cozma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2019
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/LymphomaElaine Y Chung, Yun Mai, Urvi A Shah, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Immunological consequences of macrophage-mediated clearance of apoptotic cellsSunjung Kim, Elaine Y Chung, Xiaojing Ma
Cell Research|February 14, 2006
Regulation of cytokine production during phagocytosis of apoptotic cellsElaine Y Chung, Sun Jung Kim, Xiao Jing Ma
Cancer Biology & Therapy|June 15, 2007
Aiding and ABT'ing Treatment for GlioblastomaElaine Y Chung, Michael Dews, Amit Maity, et al.
The Journal of Clinical Investigation|May 2, 2012
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesisElaine Y Chung, James N Psathas, Duonan Yu, et al.
Current Immunology Reviews|November 2, 2010
Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionJianguo Liu, Shanjin Cao, Sunjung Kim, et al.
Molecular and Cellular Biology|December 2, 2004
PRAM-1 is required for optimal integrin-dependent neutrophil functionRegina A Clemens, Sally A Newbrough, Elaine Y Chung, et al.
British Journal of Haematology|April 4, 2018
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphomaFilippo Spriano, Elaine Y Chung, Nicolo' Panini, et al.
Immunity|December 21, 2007
Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1Elaine Y Chung, Jianguo Liu, Yoichiro Homma, et al.
Cancer Biology & Therapy|August 19, 2008
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA clusterElaine Y Chung, Michael Dews, Diana Cozma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2019
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/LymphomaElaine Y Chung, Yun Mai, Urvi A Shah, et al.
Pageof 2